comparemela.com

Latest Breaking News On - Exone biologic - Page 1 : comparemela.com

NurExone Announces Voting Results from 2024 Annual Meeting

NurExone Shareholders Back Key Resolutions

EnerSpar Corp. (TSE:NRX) has released an update. NurExone Biologic Inc. shareholders showed strong support for company proposals during the 2024 An.

Enerspar-corp
Nurexone-biologic-inc
Exone-biologic

NurExone Reports First Quarter 2024 Financial Results and Provides Corporate Update, moving forward with FDA guidelines for the Human Trials

NurExone Reports First Quarter 2024 Financial Results and Provides Corporate Update, moving forward with FDA guidelines for the Human Trials
financialpost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialpost.com Daily Mail and Mail on Sunday newspapers.

United-states
Ottawa
Ontario
Canada
New-york
Toronto
Israel
Germany
Canadians
Lior-shaltiel
Eva-reuter
Joe-oconnor

Nurexone Welcomes Biopharma Exec Dr. Ram Petter To Drive Strategic Collaborations

Nurexone Welcomes Biopharma Exec Dr. Ram Petter To Drive Strategic Collaborations
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

Germany
Toronto
Ontario
Canada
Israel
Ram-petter
Lior-shaltiel
Eva-reuter
Twitter
Nurexone-biologic-inc
Facebook
Company-or-nurexone

NurExone Presenting on Revolutionary Spinal Cord Injury Therapy at European Conference on Exosomes and Regenerative Medicine

19.04.2024 - TORONTO and HAIFA, Israel, April 19, 2024 (GLOBE NEWSWIRE) - NurExone Biologic Inc. (TSXV: NRX) (Germany: J90) (the “Company” or “NurExone”), a pioneering biopharmaceutical company, is pleased to announce that Dr. Lior Shaltiel, CEO and Director . Seite 1

Germany
Canada
London
City-of
United-kingdom
Exosomes-europe
Eva-reuter
Lior-shaltiel
Nurexone-biologic-inc
Thesis-capital-inc
Facebook
Exone-biologic

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.